Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dosimetry”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT06955650
What this trial is testing

First-in-man Imaging of a New PET Radiotracer for Oxytocin Receptors

Who this might be right for
Pain, Face
Aarhus University Hospital 6
Early research (Phase 1)Study completedNCT02128945
What this trial is testing

Dosimetry and Biodistribution of [18F]-Fludarabine in Lymphoid Malignancies

Who this might be right for
Untreated B-Chronic Lymphocytic Leukemia or Diffuse Large B Cells Lymphoma Patients
University Hospital, Caen 10
Early research (Phase 1)Looking for participantsNCT07660211
What this trial is testing

Clinical Evaluation of 177Lu-PSMA-VG01 Injection in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer （mCRPC）

Who this might be right for
PSMA-positive Metastatic Castration-resistant Prostate Cancer (mCRPC)
VitsGen Therapeutics Inc. 10
Early research (Phase 1)Study completedNCT01287845
What this trial is testing

PET/CT (Positron Emission Tomography/Computed Tomography) Imaging for Safety and Tolerability and Diagnostic Performance of BAY1075553 in Patients With Prostate Cancer and Healthy Volunteers

Who this might be right for
Diagnostic Imaging
Lantheus Biosciences Ltd. 14
Not applicableUnknownNCT02374983
What this trial is testing

Gamma Knife Dosimetric Differences, TMR 10 Versus Convolution Algorithm

Who this might be right for
Gamma Knife Radiosurgery
University College, London 100
Early research (Phase 1)UnknownNCT03308682
What this trial is testing

177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Peking Union Medical College Hospital 30
Not applicableStudy completedNCT03315286
What this trial is testing

Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet Exposure

Who this might be right for
Skin CancerActinic KeratosesUltraviolet-Induced Change in Normal Skin+2 more
Weill Medical College of Cornell University 111
Early research (Phase 1)WithdrawnNCT05634954
What this trial is testing

Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
GE Healthcare
Early research (Phase 1)Active Not RecruitingNCT06229366
What this trial is testing

[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate CancerOligometastatic Prostate Carcinoma+1 more
Eli Lilly and Company 142
Early research (Phase 1)Study completedNCT00315731
What this trial is testing

Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Follicular
GlaxoSmithKline 15
Very early researchLooking for participantsNCT06636617
What this trial is testing

177Lu-JH04 in Patients with FAP-Positive Tumors

Who this might be right for
Patients with Advanced Metastatic FAP-Positive Tumors
First Affiliated Hospital of Fujian Medical University 9
Not applicableUnknownNCT06028282
What this trial is testing

Post-RAI Therapy Dosimetry and Quality Assessment of Target Tissue Dosing

Who this might be right for
Thyroid Disease
State University of New York - Upstate Medical University 10
Early research (Phase 1)Ended earlyNCT03490838
What this trial is testing

177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasm
Advanced Accelerator Applications 27
Early research (Phase 1)Looking for participantsNCT07733674
What this trial is testing

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Glioblastoma Multiforme (GBM)Pancreatic Ductal Adenocarcinoma (PDAC)
Radiomedix, Inc. 20
Very early researchLooking for participantsNCT07648823
What this trial is testing

Dosimetry, Safety, and Efficacy Study of [177Lu]Lu-XT771 in Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma (WHO-Grade IV Glioma)Recurrent GlioblastomaGlioblastoma (GBM)+1 more
Beijing Tiantan Hospital 5
Not applicableNot Yet RecruitingNCT07406126
What this trial is testing

Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases (CRCLM)Unresectable Colorectal Liver Metastases
Fernando Gómez Muñoz 30
Early research (Phase 1)Looking for participantsNCT07087197
What this trial is testing

SKB107 in Advanced Solid Tumors With Bone Metastases

Who this might be right for
Metastatic Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 90
Early research (Phase 1)Looking for participantsNCT07213791
What this trial is testing

LY4337713 in Participants With FAP-Positive Solid Tumors

Who this might be right for
Ovarian NeoplasmsBreast NeoplasmsPancreatic Intraductal Neoplasms+4 more
Eli Lilly and Company 241
Testing effectiveness (Phase 2)Study completedNCT03872778
What this trial is testing

[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-neoB Lesion Uptake

Who this might be right for
Neoplasms
Advanced Accelerator Applications 35
Not applicableUnknownNCT03946280
What this trial is testing

Utility of 3D Navigation to Reduce Ionizing Radiation in Common Flutter Ablation. Study of Personnel and Patient Dosimetry

Who this might be right for
Auricular FlutterRadiation Exposure
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 50
Next Page